DLA Piper advises REVA Medical Inc on capital raising for coronary scaffold
DLA Piper has advised Australian Securities Exchange-listed REVA Medical Inc on the issue of $25m (£15.8m) of convertible notes and also 8,750,000 options to an international investor consortium. Headquartered in San Diego, REVA Medical is developing a bioresorbable coronary scaffold for cardiovascular disease. The device provides a temporary support and drug supply for an artery […]